Analysts Offer Insights on Financial Companies: Metlife (MET), Marex Group plc (MRX) and Allstate (ALL)
Analysts have been eager to weigh in on the Financial sector with new ratings on Metlife (MET), Marex Group plc (MRX) and Allstate (ALL).
End of Quarter Sale - 50% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Metlife (MET)
In a report released today, John Barnidge from Piper Sandler maintained a Hold rating on Metlife, with a price target of $81.00. The company’s shares closed last Wednesday at $71.17.
According to TipRanks.com, Barnidge is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Metlife with a $91.80 average price target.
See Insiders’ Hot Stocks on TipRanks >>
Marex Group plc (MRX)
In a report released today, William Katz from TD Cowen reiterated a Buy rating on Marex Group plc, with a price target of $66.00. The company’s shares closed last Wednesday at $43.05.
According to TipRanks.com, Katz is a 5-star analyst with an average return of
Marex Group plc has an analyst consensus of Strong Buy, with a price target consensus of $56.83, which is a 27.6% upside from current levels. In a report issued on March 28, TipRanks – DeepSeek also upgraded the stock to Buy with a $49.00 price target.
Allstate (ALL)
In a report released today, Andrew Kligerman from TD Cowen maintained a Hold rating on Allstate. The company’s shares closed last Wednesday at $204.10, close to its 52-week high of $212.91.
According to TipRanks.com, Kligerman is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Allstate with a $238.92 average price target.
Read More on MET:
